Marc Funk
Lonza and Chr. Hansen Join to Accelerate Momentum in Microbiome
Denmark-based Chr. Hansen Holding A/S and Lonza AG have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture will be a 50/50 controlled legal entity that will ...
Lonza to Divest Peptides Business to PolyPeptide
Lonza (Switzerland) and the PolyPeptide Group (Belgium) jointly announced that PolyPeptide Laboratories Holding (PPL) AB has entered into a definitive agreement with Lonza Sales AG and Lonza AG (both 100 percent affiliates of Lonza Group AG) to acquire the peptides business and operations of Lonza in Braine-l’Alleud, Belgium. Lonza’s Braine facility, with approximately 280 employees, ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
